Literature DB >> 6193382

Stimulation of cellular function by thymopentin (TP-5) in three AIDS patients.

F Mascart-Lemone, K Huygen, N Clumeck, D Brenez, K Bolla, J Duchateau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6193382     DOI： 10.1016/s0140-6736(83)92271-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Prevention of recurrences in frequently relapsing herpes labialis with thymopentin. A randomized double-blind placebo-controlled multicenter study.

Authors:  K Bolla; D Djawari; E M Kokoschka; J Petres; S Lidén; R Gonseth; P Amblard; M G Bernengo; J J Bonerandi; A Claudy
Journal:  Surv Immunol Res       Date:  1985

2.  Enhancing of anti-viral activity against HIV-1 by stimulation of CD8+ T cells with thymic peptides.

Authors:  H Müller; G Mayer; B Behnke; E Heimüller; G Hamscher; D Immler; C Siethoff; H E Meyer; M Schreiber
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

Review 3.  Preliminary results on clinical and immunological effects of thymus hormone preparations in AIDS.

Authors:  P Hermans; N Clumeck
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

4.  Thymopentin ameliorates dextran sulfate sodium-induced colitis by triggering the production of IL-22 in both innate and adaptive lymphocytes.

Authors:  Qiuhua Cao; Xinghua Gao; Yanting Lin; Chongxiu Yue; Yue Wang; Fei Quan; Zixuan Zhang; Xiaoxuan Liu; Yuan Lu; Yanling Zhan; Hongbao Yang; Xianjing Li; Di Qin; Lutz Birnbaumer; Kun Hao; Yong Yang
Journal:  Theranostics       Date:  2019-10-12       Impact factor: 11.556

5.  Targeting the TLR2 Receptor With a Novel Thymopentin-Derived Peptide Modulates Immune Responses.

Authors:  Xubiao Wei; Lulu Zhang; Rijun Zhang; Rujuan Wu; James N Petitte; Yanfei Hou; Dayong Si; Baseer Ahmad; Henan Guo; Manyi Zhang; Qiang Cheng; Yucui Tong
Journal:  Front Immunol       Date:  2021-05-27       Impact factor: 7.561

6.  In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins.

Authors:  Irene Maffucci; Alessandro Contini
Journal:  J Proteome Res       Date:  2020-09-21       Impact factor: 4.466
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.